Cargando…

Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies

The uneventful progression through the cell cycle is closely associated with the rhythm set by the circadian clock machinery, with the S-phase of the cell cycle typically occurring at night. Presence of unrepaired DNA damage may reset the phase of the circadian clock, providing opportunities for dam...

Descripción completa

Detalles Bibliográficos
Autores principales: Uth, Kristin, Sleigh, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433803/
https://www.ncbi.nlm.nih.gov/pubmed/26019524
http://dx.doi.org/10.1080/13102818.2014.925298
_version_ 1782371671543382016
author Uth, Kristin
Sleigh, Roger
author_facet Uth, Kristin
Sleigh, Roger
author_sort Uth, Kristin
collection PubMed
description The uneventful progression through the cell cycle is closely associated with the rhythm set by the circadian clock machinery, with the S-phase of the cell cycle typically occurring at night. Presence of unrepaired DNA damage may reset the phase of the circadian clock, providing opportunities for damage assessment, repair and/or the induction of pro-apoptotic pathways. The core proteins of the circadian clock regulate directly or indirectly a significant number of genes coding for proteins involved in checkpoint transition, cell proliferation and programmed cell death. Disruption of the circadian rhythm may increase the risk for some multifactorial diseases and conditions, including glucose intolerance, cardiovascular disease and various common cancers. In patients with cancer, chronic circadian misalignment may stimulate the growth of tumours and may modify the outcomes of anticancer therapy. Knowledge about the role of physiological rhythms in human disease may contribute to the field of individualized medicine, specifically, in risk assessment and prognostication of the outcomes in patients with multifactorial disease.
format Online
Article
Text
id pubmed-4433803
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-44338032015-05-25 Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies Uth, Kristin Sleigh, Roger Biotechnol Biotechnol Equip Reviews; Medical Biotechnology The uneventful progression through the cell cycle is closely associated with the rhythm set by the circadian clock machinery, with the S-phase of the cell cycle typically occurring at night. Presence of unrepaired DNA damage may reset the phase of the circadian clock, providing opportunities for damage assessment, repair and/or the induction of pro-apoptotic pathways. The core proteins of the circadian clock regulate directly or indirectly a significant number of genes coding for proteins involved in checkpoint transition, cell proliferation and programmed cell death. Disruption of the circadian rhythm may increase the risk for some multifactorial diseases and conditions, including glucose intolerance, cardiovascular disease and various common cancers. In patients with cancer, chronic circadian misalignment may stimulate the growth of tumours and may modify the outcomes of anticancer therapy. Knowledge about the role of physiological rhythms in human disease may contribute to the field of individualized medicine, specifically, in risk assessment and prognostication of the outcomes in patients with multifactorial disease. Taylor & Francis 2014-05-04 2014-07-24 /pmc/articles/PMC4433803/ /pubmed/26019524 http://dx.doi.org/10.1080/13102818.2014.925298 Text en © 2014 The Author(s). Published by Taylor & Francis. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Reviews; Medical Biotechnology
Uth, Kristin
Sleigh, Roger
Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies
title Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies
title_full Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies
title_fullStr Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies
title_full_unstemmed Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies
title_short Deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. Part II. In vivo studies
title_sort deregulation of the circadian clock constitutes a significant factor in tumorigenesis: a clockwork cancer. part ii. in vivo studies
topic Reviews; Medical Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433803/
https://www.ncbi.nlm.nih.gov/pubmed/26019524
http://dx.doi.org/10.1080/13102818.2014.925298
work_keys_str_mv AT uthkristin deregulationofthecircadianclockconstitutesasignificantfactorintumorigenesisaclockworkcancerpartiiinvivostudies
AT sleighroger deregulationofthecircadianclockconstitutesasignificantfactorintumorigenesisaclockworkcancerpartiiinvivostudies